Login

Driving Ambition: Oxford Metrics features Chris Barnes, CEO of Tracsis Plc, segment by Cavendish 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Challenger Exploration: Advancing High-Grade Gold Projects in Argentina and Ecuador
00:10:00
Current Trends and Future Prospects in the European Fundraising Market: A Conversation with Gordon Binet | Gordon Bajnai, Chairman , Campbell Lutyens.
00:10:00
Rick Rule on Financial Resilience and Market Insights Amidst Uncertainty
00:10:00
Analyzing the Biotechnology Market: Insights into Trends, Challenges, and Future Outlook | André Choulika, CEO,Cellectis SA.
00:10:00
Robert Jon Hendricks: Embracing Black History Month at Morgan Lewis
00:10:00
Infrastructure Insights: Peter Meany on the Case for Listed Assets | Peter Meany – Head of Global Listed Infrastructure, First Sentier Investors
00:10:00
Old Peak Finance: The Smartest Way for Retirees to Give with Qualified Charitable Distributions (QCDs)
00:10:00
Investing Along the Z-Axis with Airbus Ventures|Lewis Pinault,Partner,Asia Japan & The Pacific,Airbus Ventures
00:10:00
Pioneering Sustainability and Leading Global Change | Hakan Bulgurlu, CEO, Arçelik AS.
00:10:00
Tolga Kumova Discusses Strategic Drilling Success in Ontario’s Edleston Project | Tolga Kumova , Chairman, Aston Minerals Limited.
00:10:00
Eco-Floor: Revolutionizing the Container Industry with Sustainable Innovation
00:10:00
JLL CEO Reflects on Transformative Leadership and Digital Evolution | Christian Ulbrich, CEO,  JLL Partners.

© 2026 Nehu